Welcome to GCS-2014...!
The Global Cancer Summit-2014 aims to bring in awareness on Cancer Diagnosis and Therapy that would benefit the mankind as a whole. The word "Cancer" instills a fear in every mind and is like pronouncing a death sentence on one afflicted with it. While it is true that Cancer is devastating disease not only for the family, but the society in general in terms of suffering and cost of treatment....
Global Cancer Summit-2014
The International Cancer conference 2014 program has been developed around a fundamental concept that, Cancer is not a single disease, Specific biological processes and distinct gene pathways are associated with prognosis of the disease and its sensitivity to chemotherapy, radiotherapy and targeted agents in different subtypes of cancers. A primary challenge for future treatment of patients with cancer will be to distinguish genes and pathways that “drive” cancer proliferation from genes and pathways that have no primary role in the development of cancer. The identification of functional pathways that are enriched for mutated genes will select sub-population of patients that will most likely be sensitive to chemotherapy or to biology driven targeted agents, this might help us personalize treatment according to specific subtypes of cancer, in order to maximize efficacy while minimizing the extent of treatment. The detailed understanding of the above said biological process will open new gates for cancer prevention, diagnosis, and treatment regimes.
One of the most important factors in the survival of cancer patients is detection at an early stage. Clinical assays that detect the early events of cancer offer an opportunity to intervene and prevent cancer progression. Biomarkers are important molecular signatures of the phenotype of a cell that aid in early cancer detection and risk assessment. Although new information and technologies are clearly important for new biomarker discovery, we face major hurdles in translating new findings into clinical application. During this Cancer conference, we discuss examples of recent advances and limitations in cancer biomarker identification and validation, and the implications for cancer prevention.
These continued advancements in cancer therapies are allowing us to tailor the treatment to each individual patient in order to achieve cost effective, best results, fewer side effects and overall better outcomes. This conference will address this very important aspect and pave a platform to amalgamate the basic research and translational sciences.
Dedicated to the soul of Late. Edward Moore "Ted" Kennedy
Edward Moore "Ted" Kennedy (February 22, 1932 – August 25, 2009) was the senior United States Senator from Massachusetts and a member of the Democratic Party. He was the second most senior member of the Senate when he died and was the fourth-longest-serving senator in United States history, having served there for almost 47 years....
Edward Moore "Ted" Kennedy
With the passing of Edward M Kennedy on August 25, 2009, the cancer research community lost a friend and passionate advocate of its cause.
Kennedy was the driving force behind improving health care and research policy in the U.S. Senate as well as a tireless champion in the fight against cancer. In 1971, he authored and fought for the passage of the landmark National Cancer Act which gave new power to the National Cancer Institute elevated its stature within the National Institutes of Health and initiated a renewed focus on cancer research.
More recently, Kennedy took up the mantle again, engaging the cancer community in the effort to craft the 21st Century Cancer ALERT Act. The legislation, introduced in April, 2009 aims to modernize the war on cancer by accelerating the search for cures, more effective treatments and better preventive measures while addressing the ongoing needs of cancer patients. The bill was essentially put on hold when the attention of Congress turned to health care reform earlier this year.
Even after his cancer diagnosis forced him to leave Washington last year, Kennedy, the chair of the powerful Senate Health, Education, Labor and Pensions (HELP) Committee, continued to be actively involved in the debate over health care reforms. As one of the most respected members in congress and a master at forging bipartisan compromise, his presence will be sorely missed in the increasingly contentious debate.
With all great respect, we wish to dedicate this Global Cancer Summit to Late Edward Kennedy for his tireless fight against cancer and being the force behind our knowledge of cancer today.
The main theme of the conference is "Recent Advances in Cancer Diagnosis and Therapy"